Wirtz RM - Search Results

1

Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer.

Erber R, Stöhr R, Herlein S, Giedl C, Rieker RJ, Fuchs F, Ficker JH, Hartmann A, Veltrup E, Wirtz RM, Brueckl WM. Erber R, et al. Among authors: wirtz rm. Anticancer Res. 2017 Dec;37(12):6771-6778. doi: 10.21873/anticanres.12137. Anticancer Res. 2017. PMID: 29187455

2

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Brueckl WM, Schoeberl A, Wirtz RM, Murray S, Hahn EG, Wiest GH. Brueckl WM, et al. Among authors: wirtz rm. J Thorac Oncol. 2008 Mar;3(3):314-6. doi: 10.1097/JTO.0b013e3181654423. J Thorac Oncol. 2008. PMID: 18317076 Free article.

3

Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.

Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, Dimmler A, Dorlaque L, Hohenberger W, Hahn EG, Brueckl WM. Gentner B, et al. Among authors: wirtz rm. Anticancer Res. 2009 Jan;29(1):67-74. Anticancer Res. 2009. PMID: 19331134 Free article.

4

Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.

Zamagni C, Wirtz RM, De Iaco P, Rosati M, Veltrup E, Rosati F, Capizzi E, Cacciari N, Alboni C, Bernardi A, Massari F, Quercia S, D'Errico Grigioni A, Dietel M, Sehouli J, Denkert C, Martoni AA. Zamagni C, et al. Among authors: wirtz rm. Endocr Relat Cancer. 2009 Dec;16(4):1241-9. doi: 10.1677/ERC-08-0342. Epub 2009 Sep 11. Endocr Relat Cancer. 2009. PMID: 19749010

5

Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method.

Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, Merkelbach-Bruse S, Schneider-Stock R, Stoehr R, Wirtz RM, Kitz J, Müller A, Hartmann A, Becker H, Ghadimi BM, Liersch T, Rüschoff J. Gehoff A, et al. Among authors: wirtz rm. Am J Surg Pathol. 2012 Feb;36(2):202-13. doi: 10.1097/PAS.0b013e31823fa35b. Am J Surg Pathol. 2012. PMID: 22251939

6

Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.

Brueckl WM, Al-Batran SE, Ficker JH, Claas S, Atmaca A, Hartmann A, Rieker RJ, Wirtz RM. Brueckl WM, et al. Among authors: wirtz rm. Int J Cancer. 2013 Oct 15;133(8):1825-31. doi: 10.1002/ijc.28209. Epub 2013 May 7. Int J Cancer. 2013. PMID: 23580323 Free article.

7

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Fountzilas E, Kotoula V, Angouridakis N, Karasmanis I, Wirtz RM, Eleftheraki AG, Veltrup E, Markou K, Nikolaou A, Pectasides D, Fountzilas G. Fountzilas E, et al. Among authors: wirtz rm. PLoS One. 2013 Aug 9;8(8):e70429. doi: 10.1371/journal.pone.0070429. eCollection 2013. PLoS One. 2013. PMID: 23950933 Free PMC article.

8

The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.

Atmaca A, Al-Batran SE, Wirtz RM, Werner D, Zirlik S, Wiest G, Eschbach C, Claas S, Hartmann A, Ficker JH, Jäger E, Brueckl WM. Atmaca A, et al. Among authors: wirtz rm. Int J Cancer. 2014 May 15;134(10):2314-21. doi: 10.1002/ijc.28571. Epub 2013 Nov 14. Int J Cancer. 2014. PMID: 24174373 Free article.

9

Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.

Koumarianou A, Tzeveleki I, Mekras D, Eleftheraki AG, Bobos M, Wirtz R, Fountzilas E, Valavanis C, Xanthakis I, Kalogeras KT, Basdanis G, Pentheroudakis G, Kotoula V, Fountzilas G. Koumarianou A, et al. Anticancer Res. 2014 Sep;34(9):4949-62. Anticancer Res. 2014. PMID: 25202077

10

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.

Koutras A, Kalogeras KT, Wirtz RM, Alexopoulou Z, Bobos M, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Pentheroudakis G, Pisanidis N, Magkou C, Christodoulou C, Bafaloukos D, Papakostas P, Aravantinos G, Pectasides D, Kalofonos HP, Fountzilas G. Koutras A, et al. Among authors: wirtz rm. J Transl Med. 2015 May 29;13:171. doi: 10.1186/s12967-015-0530-0. J Transl Med. 2015. PMID: 26021752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page